Goldman Sachs
ASPN icon

Goldman Sachs’s Aspen Aerogels ASPN Stock Holding History

Goldman Sachs’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.08M Sell
899,513
-395,415
-31% -$1.33M ﹤0.01% 4147
2025
Q4 		$3.66M Sell
1,294,928
-124,876
-9% -$644K ﹤0.01% 4037
2025
Q3 		$9.88M Sell
1,419,804
-782,096
-36% -$5.51M ﹤0.01% 2976
2025
Q2 		$13M Buy
2,201,900
+927,544
+73% +$5.34M ﹤0.01% 2519
2025
Q1 		$8.14M Buy
1,274,356
+602,586
+90% +$5.81M ﹤0.01% 2886
2024
Q4 		$7.98M Buy
671,770
+281,013
+72% +$4.79M ﹤0.01% 3003
2024
Q3 		$10.8M Sell
390,757
-50,369
-11% -$1.26M ﹤0.01% 2629
2024
Q2 		$10.5M Buy
441,126
+223,972
+103% +$5.26M ﹤0.01% 2460
2024
Q1 		$3.82M Sell
217,154
-5,253
-2% -$77.4K ﹤0.01% 3340
2023
Q4 		$3.51M Sell
222,407
-143,129
-39% -$1.48M ﹤0.01% 3466
2023
Q3 		$3.14M Buy
365,536
+3,202
+0.9% +$22.7K ﹤0.01% 3390
2023
Q2 		$2.86M Buy
362,334
+9,733
+3% +$67.7K ﹤0.01% 3599
2023
Q1 		$2.63M Buy
352,601
+95,051
+37% +$945K ﹤0.01% 3639
2022
Q4 		$3.04M Sell
257,550
-96,770
-27% -$1.11M ﹤0.01% 3605
2022
Q3 		$3.27M Buy
354,320
+145,317
+70% +$1.76M ﹤0.01% 3529
2022
Q2 		$2.06M Buy
209,003
+34,386
+20% +$694K ﹤0.01% 4018
2022
Q1 		$6.02M Buy
174,617
+132,232
+312% +$4.29M ﹤0.01% 3182
2021
Q4 		$2.11M Buy
42,385
+22,147
+109% +$1.17M ﹤0.01% 4201
2021
Q3 		$931K Sell
20,238
-35,459
-64% -$1.41M ﹤0.01% 4802
2021
Q2 		$1.67M Sell
55,697
-7,971
-13% -$163K ﹤0.01% 4365
2021
Q1 		$1.29M Buy
63,668
+51,779
+436% +$1.09M ﹤0.01% 4405
2020
Q4 		$198K Buy
+11,889
New +$156K ﹤0.01% 5095
2020
Q2 		– Sell
-78,010
Closed -$479K – 5189
2020
Q1 		$479K Buy
78,010
+65,295
+514% +$530K ﹤0.01% 4245
2019
Q4 		$99K Buy
+12,715
New +$87.8K ﹤0.01% 5043
2017
Q4 		– Sell
-14,379
Closed -$63K – 6329
2017
Q3 		$63K Buy
+14,379
New +$62.8K ﹤0.01% 6202
2016
Q3 		– Sell
-23,512
Closed -$117K – 7003
2016
Q2 		$117K Sell
23,512
-2,063
-8% -$9.04K ﹤0.01% 6049
2016
Q1 		$115K Buy
+25,575
New +$116K ﹤0.01% 6002
2015
Q4 		– Sell
-13,787
Closed -$103K – 7129
2015
Q3 		$103K Sell
13,787
-7,232
-34% -$52.7K ﹤0.01% 6461
2015
Q2 		$139K Buy
+21,019
New +$144K ﹤0.01% 6425

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Goldman Sachs's ASPN Position: Q1 2026 in Review

Goldman Sachs reduced its Aspen Aerogels (ASPN) stake by 31% in Q1 2026, selling an estimated $1.33M and leaving 899,513 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #4147.

Goldman Sachs first reported a position in ASPN in Q2 2015 and has held it in 29 quarters since. The position peaked at $13M in Q2 2025. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Goldman Sachs held 899,513 shares of Aspen Aerogels worth $3.08M as of Q1 2026.
  • Goldman Sachs sold 395,415 Aspen Aerogels shares in Q1 2026, an estimated $1.33M.
  • Aspen Aerogels made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4147 holding.
  • Goldman Sachs first reported a position in Aspen Aerogels in Q2 2015 and has held it in 29 quarters since.
  • Goldman Sachs's Aspen Aerogels position peaked at $13M in Q2 2025.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.